Drug Profile


Alternative Names: Ibaconda; Olsalazine/colchicine

Latest Information Update: 15 Jun 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Centre for Digestive Diseases
  • Developer Giaconda
  • Class Colchicum alkaloids; Salicylates
  • Mechanism of Action Lipoxygenase-cyclooxygenase inhibitors; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Irritable bowel syndrome

Most Recent Events

  • 04 Jun 2009 Retrospective analysis data from a phase I study in constipation-predominant Irritable bowel syndrome presented at the Digestive Disease Week 2009 (DDW-2009)
  • 31 Jul 2007 Phase-I clinical trials in Irritable bowel syndrome in Australia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top